Approach, Strategies and Activities, and Organizational Capacity FAQs
As indicated under Background (page 2, under “1.a”), the overall approach of this NOFO is to develop/refine practical and scientifically valid mathematical models to inform prevention and control efforts of state and local public health practitioners. A particular set of modeling questions will be discussed with the selected applicants, and it will be based on CDC priorities and LHD needs (as indicated under Approach, page 4, under “2.a”).
No. At the same time, please consider reviewing examples of previous work in publications listed in Table 1 and at the link to the full list of NEEMA publications.
As indicated under Organizational Capacity of Recipients to Implement the Approach, applicants need to demonstrate capability in all 4 diseases areas (HIV, VH, STDs, and TB). Specifically, applicants should include as part of their applications a brief 1-paragraph description of 12 hypothetical examples for each of the 6 types of economic analyses listed in Table 1 (Cost analysis; Burden of illness; Cost-effectiveness; Cost-benefit; Population-level program impact, and Resource allocation). Those 12 examples when combined should cover all 4 disease areas (HIV, VH, STDs, and TB).
As indicated under Organizational Capacity of Recipients to Implement the Approach (page 13, under “c”) and noted under Phase 2 Review Criteria (page 30, under “Organizational Capacity to Implement the Approach”), applicants should demonstrate capability in various types of economic and epidemiological analyses. Specifically, they need to include 2 examples for each of the 6 types of analyses (cost, burden of illness, cost-effectiveness, cost benefit, population level impact and resource allocation) to cover all 4 diseases areas (HIV, VH, STDs, and TB).
As indicated under Phase 2 Review criteria (page 30, Organizational Capacity to Implement The Approach section), the 6 types of economic analyses include cost, burden of illness, cost-effectiveness, cost-benefit, population level impact, and resource allocation. The other 3 – forecasting disease burden, population size estimates, and systematic review/meta-analysis – may be used to inform the main 6 models, but not as separately contributing to the 12 examples requested.
As indicated under Phase 2 Review criteria, applications will be evaluated based on applicant’s ability to provide 2 hypothetical examples for each of the 6 types of economic analyses: cost, burden of illness, cost-effectiveness, cost-benefit, population level impact, and resource allocation. The other 3 – systematic review/meta-analysis, forecasting disease burden, and population size estimates – may be used to inform the main 6 models, but not as separately contributing to the 12 examples requested. Applications are reviewed for eligibility and responsiveness during Phase I review. An objective review panel will then review and score applications based on the criteria specified in the notice under Phase II Review Criteria. This includes: “The extent to which the applicant has the epidemiologic, clinical, modeling and economic expertise sufficient to generate hypotheses, conduct literature searches, determine needed data inputs, and the ability to construct models to address all four areas.”
Yes, the page detailed description of a model is included in the 20-page limit. Please note that the detailed description is not for a “hypothetical” model, but an existing model.
Yes, Michelle Van Handel now serves as the Program Office contact for this funding opportunity.
Detailed information on CDC’s approach to economic evaluation ─ including program cost analysis, cost of illness, cost-effectiveness analysis, and cost-benefits analysis ─ is available through CDC’s Office of the Associate Director for Policy (POLARIS). For each type of analysis, POLARIS provides the definition, describes inputs and outputs, discusses relevant examples, and lists resources.
The Organizational capacity of Recipients does not specify explicit criteria for the 1-page detailed example. Please note that the detailed description is not for a “hypothetical” model, but an existing model. We expect this example to be viable and to include problem statement, modeling approach, data sources, and programmatic implications.
As mentioned under Organizational Capacity of Recipients to Implement the Approach (p.13) and noted under Phase 2 Review Criteria (p. 30), applicants should propose 2 examples for each of the 6 types of economic analyses listed in Table 1 (Cost analysis; Burden of illness; Cost-effectiveness; Cost-benefit; Population-level program impact, and Resource allocation). Those 12 examples when combined should cover all 4 disease areas (HIV, viral hepatitis, sexually transmitted diseases, and tuberculosis). For additional details, please see the Organizational Capacity of Recipients section.
A checklist is not available as a stand-alone document. Please carefully review the application requirements to ensure items such as maximum length, only required and optional attachments are included. If applications are submitted through Grants.govExternal, an error message will occur for some required information if it is missing from the application.
As mentioned under Award Information (p.15), the approximate number of awards is 3. This funding opportunity ensures a fully competitive process for all applicants. All applicants who submit an application package will first be reviewed for responsiveness (Phase 1 Review) and then scored and funded in rank order based on the Phase 2 Review criteria.
